Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)
29.55
-0.62 (-2.06%)
At close: Mar 9, 2026
29.83% (1Y)
| Market Cap | 1.71B |
| Revenue (ttm) | 174.00M |
| Net Income (ttm) | -49.88M |
| Shares Out | 55.19M |
| EPS (ttm) | -0.90 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.34 (1.15%) |
| Ex-Dividend Date | Oct 24, 2025 |
| Volume | 860,577 |
| Average Volume | 696,451 |
| Open | 29.87 |
| Previous Close | 30.17 |
| Day's Range | 28.85 - 29.97 |
| 52-Week Range | 17.50 - 36.00 |
| Beta | 0.38 |
| RSI | 46.24 |
| Earnings Date | Apr 11, 2026 |